
Home » Prescription Drugs 17 » Vitamax Joint Mobility Generic Glucosamine Chondroitin
This formulation of Gulcocamine Hydrochloride with Chondroitin assists in the maintenance of healthy cartilage and bone. Manganese and Boron are also ingredients that may help alleviate the symptoms of osteoarthritis. How it works Glucosamine is a key part of the structure of cartilage which is essential for proper joint function. As one ages cartilage becomes more susceptible to breakdown and damage which may result in the symptoms of osteoarthritis. They do not containAdded yeast starch gluten lactose sugar artificial flavours artificial sweeteners artificial preservatives or dairy products. DosageAdults Take 1 tablet daily with food or as professionally prescribed. Children (Under 12) Consult your healthcare professional.
Buy Vitamax Joint Mobility Generic Glucosamine Chondroitin and other Prescription Drugs 17 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Vitamax Joint Mobility Generic Glucosamine Chondroitin:
Product Type: Prescription Drugs 17
Vitamax Joint Mobility (Generic Glucosamine & Chondroitin)
Vitamax Joint Mobility (Generic Glucosamine & Chondroitin)
Generic Glucosamine & Chondroitin
750/25mg
Generic Glucosamine & Chondroitin Vitamax Joint Mobility

View more
Prescription Drugs 17
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|